Memberships

MetrioPharm AG

MetrioPharm Memberships

News

MetrioPharm AG Phase II Data in Psoriasis Show Dose-Response - 2019-Oct-16

The data confirm the trend towards clinical efficacy and outstanding safety profile of MP1032, the lead compound from a new class of proprietary immune modulators developed by MetrioPharm AG.

» more

Investor Relations

Investor Relations News QIV 2019 - 2019-Dec-12

Topics: Retrospect 2019, BIO-Europe, Jefferies London Healthcare Conference, Warburg Bank “Meet the future” Conference, Essay by CEO Dr. Wolfgang Brysch: "Who wants to live forever?" (Blog)

» more